Sunshine Biopharma (SBFMW) EPS (Basic) Growth (1y) (2011 - 2026)
Sunshine Biopharma (SBFMW) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 68.42% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 5.97% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -11.98% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 2,362.50% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -883.55% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -21.43% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -385.71% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 72.64% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 233.33% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | 43.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.18% |
| Dec 31, 2025 | -107.31% |
| Sep 30, 2025 | 79.79% |
| Jun 30, 2025 | 96.08% |
| Mar 31, 2025 | 78.00% |
| Dec 31, 2024 | 107.34% |
| Sep 30, 2024 | 98.15% |
| Jun 30, 2024 | 86.03% |
| Mar 31, 2024 | 74.13% |
| Dec 31, 2023 | -5,430.04% |
| Sep 30, 2023 | -63,500.00% |
| Jun 30, 2023 | -237,133.33% |
| Mar 31, 2023 | -3,260.87% |
| Dec 31, 2022 | -259.67% |
| Sep 30, 2022 | 105.03% |
| Jun 30, 2022 | 97.52% |
| Mar 31, 2022 | 91.84% |
| Dec 31, 2021 | 135.66% |
| Jun 30, 2021 | -12,000.00% |
| Dec 31, 2020 | -5,540.00% |